Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

    Fabian Herrera
    e2024039
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.039
    1580
    PDF: 1057
    HTML: 134
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2473
    PDF: 1046
    HTML: 2128
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1346
    PDF: 765
    HTML: 1481
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1575
    PDF: 818
    HTML: 774
  • COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis

    Selim SAYIN
    e2024016
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.016
    1496
    PDF: 1367
    HTML: 111
  • EPSTEIN-BARR VIRUS RELATED LYMPHOPROLIFERATIONS AFTER STEM CELL TRANSPLANTATION

    Simona Sica, Elisabetta Metafuni, Silvia Bellesi, Patrizia Chiusolo
    e2009019
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.019
    1461
    PDF: 588
    HTML: 3025
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2206
    PDF: 1023
    HTML: 1805
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1302
    PDF: 816
    HTML: 617
  • Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

    Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca
    e2018001
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.001
    4296
    PDF: 1151
    HTML: 1032
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    883
    PDF: 579
    HTML: 2461
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4402
    PDF: 1418
    HTML: 2187
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

    Fabienne McClanahan, Peter Dreger
    e2012071
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.071
    2556
    PDF: 845
    HTML: 1771
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    2396
    PDF: 1768
    HTML: 971
  • HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

    Anna Maria Testi
    e2022038
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.038
    1284
    PDF: 885
    HTML: 262
  • HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

    Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi
    e2009016
    https://doi.org/10.4084/mjhid.2009.016
    1023
    PDF: 552
    HTML: 740
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1357
    PDF: 438
    HTML: 3137
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1442
    HTML: 394
    PDF: 990
    Suppl. Files: 487
  • THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

    Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
    e2016025
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.025
    6453
    PDF: 2192
    HTML: 14145
    Untitled: 219
    figure: 203
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    1149
    PDF: 598
    Suppl. Files: 139
    HTML: 470
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1307
    PDF: 545
    HTML: 23138
  • AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS

    Grzegorz Helbig, Malgorzata Krawczyk-Kulis, Malgorzata Kopera, Krystyna Jagoda, Patrycja Rzepka, Aleksandra Majewska-Tessar, Marta Hejla, Slawomira Kyrcz-Krzemien
    e2014047
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.047
    1596
    PDF: 939
    HTML: 2009
    Figure: 196
    Tables: 205
    ALL revision 1: 292
    response to reviewer: 199
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    1041
    PDF: 658
    HTML: 2239
  • CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

    Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti
    e2024045
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.045
    3842
    PDF: 1676
    HTML: 87
  • Incident Hepatitis B Virus Infection after Hematopoietic Stem Cell Transplantation in Initially HBV-Seronegative Recipients: Four Cases

    Dangui Chen
    e2026065
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.065
    19
    PDF: 16
    Html: 2
  • Genomic integration of HHV-6 mimicking viral reactivation after autologous stem cell transplantation

    rossana mineri, Jacopo Mariotti, Barbara Sarina, Lucio Morabito, roberto crocchiolo, stefania bramanti, tiziana sarno, federica tordato, carmelo carlo-stella, armando santoro, Luca Castagna
    e2018013
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.013
    3135
    PDF: 762
    HTML: 434
  • COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA

    Sanjeev Kumar Sharma, Dharma Choudhary, Nitin Gupta, Mayank Dhamija, Vipin Khandelwal, Gaurav Kharya, Anil Handoo, Rasika Setia, Arpita Arora
    e2014046
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.046
    2841
    PDF: 1009
    HTML: 4723
  • CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

    Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori
    e2019048
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.048
    2562
    PDF: 1215
    HTML: 281
  • Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

    Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori
    e2013029
    2013-04-15
    https://doi.org/10.4084/mjhid.2013.029
    1529
    PDF: 867
    HTML: 1257
  • MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
    e2015001
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.001
    2359
    PDF: 1360
    HTML: 17203
    Bassan Fig.1: 159
    Bassan Fig.2: 260
    Bassan Fig.4: 153
    Fig.3: 225
  • LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B

    Eva Eliassen, Gerhard R Krueger, Mario Luppi, Dharam Ablashi
    e2018035
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.035
    3841
    PDF: 1636
    HTML: 841
    Figures . Eliassian: 250
  • Respiratory function in pediatric African SCA patients underwent bone marrow transplantation

    Antonella Isgrò, Javid Gaziev, Marco Marziali, Katia Paciaroni, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Festus Olusola Olowoselu, Guido Lucarelli
    e2017030
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.030
    2175
    PDF: 805
    HTML: 1075
    Spirometry in SCA patients before transplant: 227
    Spirometry in SCA patients post transplant: 198
  • DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse

    xinchen fang, Zimin Sun, Huilan Liu, Xiang Wan, Wen Yao, Kaidi Song, Kaidi Song, Baolin Tang, Xiaoyu zhu, Jun Peng
    e2021005
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.005
    1453
    PDF: 586
    HTML: 236
  • BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE

    Michele Malagola
    e2017036
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.036
    4460
    PDF: 882
    HTML: 1115
  • INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

    Corrado Girmenia, Erica Finolezzi, Vincenzo Federico
    e2011013
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.013
    2371
    PDF: 1012
    HTML: 1865
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1258
    PDF: 623
    HTML: 6899
  • DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.

    Federica Sorà, patrizia chiusolo, luca laurenti, idanna innocenti, francesco autore, sabrina giammarco, elisabetta metafuni, eleonora alma, alessia di giovanni, simona sica, andrea bacigalupo
    e2020055
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.055
    1316
    PDF: 705
    HTML: 341
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    1944
    PDF: 1202
    HTML: 336
  • LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

    kang sun
    e2024037
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.037
    2981
    PDF: 1137
    HTML: 127
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4394
    PDF: 1485
    HTML: 733
  • BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

    Maria Teresa Voso, Giulia Falconi, Dr. Fabiani
    e2023055
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.055
    1933
    PDF: 1034
    HTML: 241
  • Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient

    Poorvi Chordia, Pranatharthi H Chandrasekar
    e2014008
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.008
    1228
    PDF: 859
    HTML: 2191
    Figue 1: 190
  • FEASIBILITY OF COLLECTING UMBILICAL CORD BLOOD IN JORDAN AND THE EFFECT OF MATERNAL AND NEONATAL FACTORS ON HEMATOPOIETIC STEM CELL CONTENT

    Ayad Ahmed Hussein, Randa M. Bawadi, Lubna H. Tahtamouni, Haydar Frangoul, Ali Z. ElKarmi
    e2014019
    2014-02-18
    https://doi.org/10.4084/mjhid.2014.019
    1623
    PDF: 843
    HTML: 2051
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1212
    PDF: 789
    HTML: 588
  • TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà
    e2014052
    2014-07-02
    https://doi.org/10.4084/mjhid.2014.052
    2794
    PDF: 1402
    HTML: 5977
  • HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME

    Yuan Sun
    e2024036
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.036
    1387
    PDF: 1205
    HTML: 189
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1589
    PDF: 1218
    HTML: 544
  • INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

    Giuseppe La Torre
    e2016044
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.044
    4769
    PDF: 1524
    HTML: 3407
  • FLUDARABINE-BASED LOW-INTENSITY CONDITIONING FOR FANCONI ANEMIA IS ASSOCIATED WITH GOOD OUTCOMES IN APLASTIC ANEMIA BUT NOT IN MDS - A SINGLE-CENTER EXPERIENCE

    Biju George, Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Devasia, Anu Korula, Uday Kulkarni, Fouzia Aboobacker, Eunice Sindhuvi, Kavitha Lakshmi, Alok Srivastava, Aby Abraham, Vikram Mathews
    e2023039
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.039
    1419
    PDF: 1068
    HTML: 346
  • A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

    Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso
    e2025054
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.054
    730
    PDF: 522
    HTML: 91
  • Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

    Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza
    e2017020
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.020
    3088
    PDF: 993
    HTML: 546
51 - 100 of 195 items << < 1 2 3 4 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.